Hägersten, Sweden 9/12/2007 8:41 PM GMT (TransWorldNews) The
psychiatrist spoke out in Swedish national television, in a program
covering the illegal marketing of Zyprexa and the harmful effects of
the new so called atypical neuroleptics. Zyprexa is the 6th most sold
drug in Sweden, all categories.
Despite the fact that nine States in the US
are suing the manufacturer of Zyprexa, Eli Lilly, and despite the fact
that almost 30.000 persons have been awarded 1.2 billion dollars due to
the injuries caused by Zyprexa, there has been a complete silence about
this affair in Sweden.
Until now.
The
Professor, who according to the program has been investigating harmful
effects of drugs for the last 7 years, further said: “I’ve seen so many
complications, and I have met so many patients – that I completely
choke. Are we so damned gullible, and it must be – there is only one
thing – marketing.”
When
the reporter takes up the endocrine effects of the new neuroleptics,
Professor Adolfsson says that they are extremely dangerous. He says:
“You die prematurely, 10-15 years.” And upon the surprised follow-up
question from the reporter if he means that the pharmaceutical
industry, with these new drugs, drives persons with schizophrenia to an
early death, Dr. Adolfsson simply responds: “Absolutely!” He says:
“Everybody knows that weight gain is completely catastrophic for all
forms of illness ahead, even cancer.” And: “It is the central thing for
the development of two things: One is vascular diseases and the other
is diabetes.”
It
is further revealed that the Professor has had a long relationship with
Eli Lilly (10-15 years). He says: “And I have discussed very much with
them that you have to be trustworthy – this I maybe said 5-6 years ago
– they must come out and say: This is a very dangerous thing with our
drug, because people are gaining weight. And you must do these and
these tests, and if we have this increase in weight so quickly, then
you must switch to another drug.”
But
obviously Eli Lilly and Swedish psychiatry did not listen. At that time
the Swedish Medical Journal was filled with ads for Zyprexa, with
pictures of calm persons, and the key words for Zyprexa were:
Strenghth, Carefulness, Simplicity. And still, in 2007, the marketing
material for Zyprexa in Sweden
contains these same words. In addition to that the patient leaflet, in
its English version, contains false statements that the condition of
the patient is comparable to diabetes and the usual suggestion, that
Zyprexa gives a chemical balance in the brain. The known, serious
harmful effects are still made to nothing, with the following wording:
“People usually experience few or no side effects. Drowsiness or
dizziness may occasionally occur, and some people may experience
increased appetite, which can lead to weight increase.”
In the program Dr. Adolfsson raises the question: “Why doesn’t Swedish psychiatry react?”